541 Results

Anixa Biosciences has filed an IVD pre-submission with the FDA for use of its Cchek artificial intelligence based cancer detection technology, as a prostate cancer test.

 Added ago

Anixa Biosciences formerly ITUS Corporation , a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy...

Feraccru filed with FDA for iron deficiency.- Shield Therapeutics.

 Added 14 days ago

Shield Therapeutics has announced that it has received confirmation from the US FDA of its successful submission of an NDA...

CHMP positive for Vabomere to treat infections, namely cIAI, cUTI, HAP/VAP, bacteraemia and aerobic gram negative infections.- Melinta Therapeutics

 Added 22 days ago

Melinta Therapeutics, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...

Positive Phase III results for roxadustat in CKD patients with anemia and not on dialysis.-Astellas

 Added 23 days ago

Astellas Pharma Inc. has announced that roxadustat, an inhibitor of hypoxia ¬inducible factor (HIF) prolyl hydroxylase activity, met its primary...

JNJ 42756493 filed with the FDA for metastatic urothelial cancer.- Janssen R&D.

 Added 26 days ago

Janssen Pharmaceutical announced that a New Drug Application (NDA) has been submitted to the FDA seeking approval of JNJ 42756493...

Bavencio + Inylta positive results in Javelin Renal 101 study for renal cell carcinoma -Merck KGaA + Pfizer

 Added 1 month ago

Merck KGaA and Pfizer Inc. announced positive top-line results from the pivotal Phase III JAVELIN Renal 101 study evaluating Bavencio...

The TULIP 1 Phase III trial for anifrolumab in adult patients with moderate-to-severe systemic lupus erythematosus (SLE) did not meet the primary endpoint.- AstraZeneca

 Added 1 month ago

AstraZeneca and MedImmune, announced top-line results from the from the TULIP 1 Phase III trial for anifrolumab in adult patients...

Revisions to protocols of two trials of Xtandi in men with hormone-sensitive prostate cancer will accelerate timelines for anticipated primary completion . Pfizer + Astellas.

 Added 1 month ago

Pfizer Inc. and Astellas Pharma Inc. announced amendments to the protocols for two registrational Phase III trials, ARCHES and EMBARK,...

First Phase III trial of sulopenem + probenecid versus ciprofloxacin to treat women with UTI infections.- Iterum Therapeutics.

 Added 1 month ago

Iterum Therapeutics plc , announced its initiation of the first of three Phase III clinical trials. In this trial, known...

Positive results from proof of concept trial of NuQ assay to diagnose prostrate cancer.- VolitionRx Ltd.

 Added 2 months ago

VolitionRx Limited has announced preliminary data from a prospective, multi-centered Proof of Concept Study of 84 men into the utility...

Load more